文献速递慢阻肺

mMRC与CAT对COPD运动性呼吸困难识别能力与心肺运动试验的比较

Identifying Abnormal Exertional Breathlessness in COPD: Comparing Modified Medical Research Council and COPD Assessment Test With Cardiopulmonary Exercise Testing.
PubMed 文献 · Chest · 2024-10-28

该研究基于加拿大COPD队列318例患者,以递增心肺运动试验中Borg评分超过正常上限定义异常运动性呼吸困难,评估mMRC和CAT的识别能力。结果显示24%存在异常运动性呼吸困难,而mMRC≥2联合CAT≥10特异性95%但敏感性仅12%,各切点准确率均低于65%,提示两量表与CPET一致性低、漏诊多。

要点

  • mMRC≥2联合CAT≥10识别异常运动性呼吸困难特异性95%,但敏感性仅12%。
  • 所有mMRC和CAT切点及组合的准确率均低于65%。
  • mMRC=0或CAT<10者中分别有9%和11%存在异常运动性呼吸困难。

核心结论

  • 在COPD中,mMRC和CAT与CPET一致性低,未能识别许多存在异常高运动性呼吸困难的患者。

研究设计与样本

  • 加拿大COPD队列分析,纳入≥40岁、支气管舒张后FEV1/FVC<0.70且吸烟≥10包年的318例COPD患者(40%女性)。
  • 以递增心肺运动试验症状限制峰值时Borg评分超过正常上限定义异常运动性呼吸困难。

主要发现

  • 318例患者平均(SD)年龄66.5(9.3)岁,FEV1占预计值79.5%(19.0%)。
  • 26%患者运动能力异常低下(峰值摄氧量低于正常下限)。
  • 24%存在异常高运动性呼吸困难,其中mMRC评分0者占9%,CAT评分<10者占11%。
  • mMRC≥2和CAT≥10检测异常运动性呼吸困难特异性最高(95%),但敏感性仅12%。

关键数值与推荐

  • mMRC评分≥2和CAT评分≥10联合检测异常运动性呼吸困难特异性95%,敏感性12%。
  • 所有量表切点或组合的准确率均<65%。

临床怎么用

  • mMRC和CAT不能可靠识别COPD患者的异常运动性呼吸困难,低评分者仍需关注运动耐量评估。
  • 对症状负担低但怀疑运动性呼吸困难者,可考虑心肺运动试验进一步评估。

局限性

  • 研究基于加拿大COPD队列,结果外推需谨慎。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: COPD management is guided by the respiratory symptom burden, assessed using the modified Medical Research Council (mMRC) scale, the COPD Assessment Test (CAT), or both. RESEARCH QUESTION: What are the abilities of mMRC and CAT to detect abnormally high exertional breathlessness on incremental cardiopulmonary cycle exercise testing (CPET) in people with COPD? STUDY DESIGN AND METHODS: Analysis of people aged ≥ 40 years with FEV1 to FVC ratio of < 0.70 after bronchodilator administration and ≥ 10 pack-years of smoking from the Canadian Cohort Obstructive Lung Disease study. Abnormal exertional breathlessness was defined as a breathlessness (Borg scale 0-10) intensity rating more than the upper limit of normal at the symptom-limited peak of CPET using normative reference equations. RESULTS: We included 318 people with COPD (40% female) with a mean (SD) age of 66.5 (9.3) years and FEV1 of 79.5% predicted (19.0% predicted); 26% showed abnormally low exercise capacity (peak oxygen uptake less than the lower limit of normal). Abnormally high exertional breathlessness was present in 24%, including 9% and 11% of people with mMRC score of 0 and CAT score of < 10, respectively. An mMRC score of ≥ 2 and CAT score of ≥ 10 was most specific (95%) to detect abnormal exertional breathlessness, but showed low sensitivity of only 12%. Accuracy for all scale cutoffs or combinations was < 65%. Compared with people with true-negatives findings, people with abnormal exertional breathlessness but low mMRC score, low CAT scores (false-negatives findings), or both showed worse self-reported and physiologic outcomes during CPET, were more likely to have physician-diagnosed COPD, but were not more likely to be taking any respiratory medication (37% vs 30%; mean difference, 6.1%; 95% CI, -7.2 to 19.4; P= .36). INTERPRETATION: In COPD, mMRC and CAT showed low concordance with CPET and failed to identify many people with abnormally high exertional breathlessness. CLINICAL TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT00920348; URL: www. CLINICALTRIALS: gov.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Ekström M, Lewthwaite H, Li PZ, et al. Identifying Abnormal Exertional Breathlessness in COPD: Comparing Modified Medical Research Council and COPD Assessment Test With Cardiopulmonary Exercise Testing. Chest. 2024. PMID: 39490971. doi:10.1016/j.chest.2024.10.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。